| (1) PPARγ ligands inhibit cancer cell growth and induce apoptosis via: |
| PGreceptors (e.g., EP2 and EP4) | Tumor suppressors (e.g., PTEN, p21) | Inflammatory factors (e.g., NF-κB, MCP-1, COX-2) | Angiogenic factors (e.g., VEGF) | Survival factors (e.g., PI3-K/Akt, mTOR) | Other kinase signals (e.g., ERK, p38 MAPK) | Growth factor receptors (e.g., EGF-R, PDGF-R) | Extracellular matrices (e.g., fibronectin,MMP-9) | Integrin receptors (e.g., α5β1) |
Others (e.g., cytokines (e.g., IL-13, IL-21, TGF-β1) and chemokines (e.g., MIP-1β)) |
|
|